ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

ADNAN ALGHADBAN M.D.

527 MEDICAL PARK DRIVE, STE. 204 ASSOCIATED SPECIALISTS, INC.

Bridgeport | West Virginia | 26330

(304) 933-3800

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Neurology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,347Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 45

$739K Total Retail Price of All Prescriptions

Rank: 11 out of 45

742 Patients Receiving at Least One Drug in Part D
55%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 742 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

7% of this provider’s 742 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

5% of this provider’s 3,010 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$116 was the average price of a prescription from this provider, compared to $229 among peers.

Prescriptions per Patient

9 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
GABAPENTIN 680 357 1 1
DIVALPROEX SODIUM 338 208 2 15
TOPIRAMATE 321 44 3 4
MELOXICAM 282 153 4 32
HYDROCODONE-ACETAMINOPHEN 255 154 S3 5 5
CARBIDOPA-LEVODOPA 244 215 6 3
DONEPEZIL HCL 227 176 7 7
TIZANIDINE HCL 214 59 8 13
PRIMIDONE 213 134 9 10
NAMENDA 183 171 10 12
AMITRIPTYLINE HCL 168 98 R 11 8
LYRICA 160 17 12 9
LEVETIRACETAM 150 52 13 2
CARBAMAZEPINE 145 43 14 18
ROPINIROLE HCL 131 88 15 11
PRAMIPEXOLE DIHYDROCHLORIDE 128 92 16 24
ZONISAMIDE 124 20 17 25
LAMOTRIGINE 112 0 18 6
PROPRANOLOL HCL 103 52 19 21
LIDOCAINE-PRILOCAINE 87 42 20 76
VIMPAT 87 15 20 22
PREDNISONE 82 61 22 50
ETODOLAC 77 25 23 80
METHADONE HCL 76 33 S2 24 47
PHENYTOIN SODIUM EXTENDED 76 0 24 14
FLUOXETINE HCL 66 12 26 68
PYRIDOSTIGMINE BROMIDE 66 56 26 42
FENTANYL 61 31 S2 28 39
COPAXONE 60 0 29 33
SUMATRIPTAN SUCCINATE 59 0 30 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 3, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.